In 2017, the value of the global cell therapy market was 5.22 billion US dollars (Grand View Research, 2018). The market value is expected to reach $ 7.92 billion in 2025, with a cumulative annual growth rate (CAGR) of 5.34 percent.

The pharmaceutical market in Southeast Asia has reported significant growth, with Thailand being the second largest market after Indonesia. The market value of Thai pharmaceuticals amounted to 2.34 billion baht in 2018,  with a 3-5 percent growth rate per annum.

The Thai medical device industry is expected to grow at an average rate of 6.71 percent annually between 2020 and 2021

In recent years, consumers worldwide have become increasingly interested in healthcare and fitness. They seek information about preventive healthcare measures including a healthy diet and exercise regimen

Precision medicine is utilized in Thailand for various applications such as oncology, rare and undiagnosed diseases, non-invasive prenatal testing (NIPT), newborn screening and health, pharmacogenomics and wellness promotion.

There might be misconception that robot needs to be in humanoid form that composes of head, legs, and arms. However, it is not necessary for robot to be humanlike, but only a robotic arm would be enough and it is widely used within the industrial plant and production.

          Cosmetics or beauty and personal care are one of the important businesses in Thailand, which are not only have high market values but are also on a rising trend.

Currently, there are 2,000 patients under the clinical trial research and development of genomic or genetic cell and gene therapy.